Indivior (INDV) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

29 December 2014

Indexes:

Not included

Description:

Indivior is a global pharmaceutical company focused on developing treatments for addiction and mental health disorders. They specialize in medications for opioid dependence and other related conditions, aiming to improve patients' lives through innovative therapies and support services.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Oct 24, 2024

Recent annual earnings:

Feb 22, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

June 16, 2016
Splits

Next split:

N/A

Recent split:

Oct 10, 2022

Analyst ratings

Recent major analysts updates

25 Oct '24 Piper Sandler
Overweight
11 Oct '24 Piper Sandler
Overweight
11 Oct '24 Craig-Hallum
Buy
13 Sept '24 Piper Sandler
Overweight
23 July '24 Piper Sandler
Overweight
10 July '24 Craig-Hallum
Buy
03 Apr '24 Craig-Hallum
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
INDV
accesswire.com28 September 2024

NEW YORK, NY / ACCESSWIRE / September 28, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=105806&wire=1 or contact Joseph E. Levi, Esq.

October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
INDV
accesswire.com25 September 2024

NEW YORK, NY / ACCESSWIRE / September 25, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=105014&wire=1 or contact Joseph E. Levi, Esq.

October 1, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against INDV
INDV
prnewswire.com23 September 2024

NEW YORK , Sept. 23, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Indivior PLC (NASDAQ: INDV).

October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
INDV
accesswire.com16 September 2024

NEW YORK, NY / ACCESSWIRE / September 16, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=102884&wire=1 or contact Joseph E. Levi, Esq.

INVESTOR ALERT: DiCello Levitt LLP Shareholder Class Action Lawsuit Filed Against Indivior PLC (NASDAQ: INDV); Investors with Losses Encouraged to Discuss Their Options with Counsel
INVESTOR ALERT: DiCello Levitt LLP Shareholder Class Action Lawsuit Filed Against Indivior PLC (NASDAQ: INDV); Investors with Losses Encouraged to Discuss Their Options with Counsel
INVESTOR ALERT: DiCello Levitt LLP Shareholder Class Action Lawsuit Filed Against Indivior PLC (NASDAQ: INDV); Investors with Losses Encouraged to Discuss Their Options with Counsel
INDV
globenewswire.com13 September 2024

SAN DIEGO, Sept. 13, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of purchasers or acquirers of Indivior PLC (NASDAQ: INDV) (“Indivior” or the “Company”) securities between February 22, 2024 and July 8, 2024, inclusive (the “Class Period”), charging the Company and certain senior executives with violations of the federal securities laws (collectively, “Defendants”).

October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
INDV
globenewswire.com11 September 2024

NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Indivior PLC ("Indivior" or the "Company") (NASDAQ: INDV) of a class action securities lawsuit.

October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
INDV
accesswire.com31 August 2024

NEW YORK, NY / ACCESSWIRE / August 31, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=99436&wire=1 or contact Joseph E. Levi, Esq.

October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
INDV
accesswire.com21 August 2024

NEW YORK, NY / ACCESSWIRE / August 21, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=97288&wire=1 or contact Joseph E. Levi, Esq.

October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
INDV
accesswire.com21 August 2024

NEW YORK, NY / ACCESSWIRE / August 21, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=97211&wire=1 or contact Joseph E. Levi, Esq.

October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
October 1, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INDV
INDV
accesswire.com20 August 2024

NEW YORK, NY / ACCESSWIRE / August 20, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=96929&wire=1 or contact Joseph E. Levi, Esq.

FAQ

  • What is the primary business of Indivior?
  • What is the ticker symbol for Indivior?
  • Does Indivior pay dividends?
  • What sector is Indivior in?
  • What industry is Indivior in?
  • What country is Indivior based in?
  • When did Indivior go public?
  • Is Indivior in the S&P 500?
  • Is Indivior in the NASDAQ 100?
  • Is Indivior in the Dow Jones?
  • When was Indivior's last earnings report?
  • When does Indivior report earnings?
  • Should I buy Indivior stock now?

What is the primary business of Indivior?

Indivior is a global pharmaceutical company focused on developing treatments for addiction and mental health disorders. They specialize in medications for opioid dependence and other related conditions, aiming to improve patients' lives through innovative therapies and support services.

What is the ticker symbol for Indivior?

The ticker symbol for Indivior is NASDAQ:INDV

Does Indivior pay dividends?

No, Indivior does not pay dividends

What sector is Indivior in?

Indivior is in the Healthcare sector

What industry is Indivior in?

Indivior is in the Drug Manufacturers - Specialty & Generic industry

What country is Indivior based in?

Indivior is headquartered in United States

When did Indivior go public?

Indivior's initial public offering (IPO) was on 29 December 2014

Is Indivior in the S&P 500?

No, Indivior is not included in the S&P 500 index

Is Indivior in the NASDAQ 100?

No, Indivior is not included in the NASDAQ 100 index

Is Indivior in the Dow Jones?

No, Indivior is not included in the Dow Jones index

When was Indivior's last earnings report?

Indivior's most recent earnings report was on 24 October 2024

When does Indivior report earnings?

The date for Indivior's next earnings report has not been announced yet

Should I buy Indivior stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions